Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAzurRx BioPharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/16/2021 | Q2 2021 | -$0.72 | -$1.19 | -0.47 | N/A | $0 |
| 05/24/2021 | Q1 2021 | -$0.72 | -$1.39 | -0.67 | N/A | $0 |
| 11/16/2020 | Q3 2020 | -$1.36 | -$0.00 | 1.36 | N/A | $0 |
| 08/14/2020 | Q2 2020 | -$1.06 | -$1.68 | -0.62 | N/A | $0 |
| 05/15/2020 | Q1 2020 | -$1.17 | -$1.95 | -0.78 | N/A | $0 |
| 03/30/2020 | Q4 2019 | -$1.60 | -$0.48 | 1.12 | N/A | $0 |
| 11/14/2019 | Q3 2019 | -$1.57 | -$1.68 | -0.11 | N/A | $0 |
| 08/12/2019 | Q2 2019 | -$0.21 | -$2.46 | -2.25 | N/A | $0 |
| 04/01/2019 | Q1 2019 | -$0.18 | -$2.63 | -2.45 | N/A | $0 |
| 04/01/2019 | Q4 2018 | -$0.18 | -$2.27 | -2.09 | N/A | $0 |
| 11/09/2018 | Q3 2018 | -$0.20 | -$1.52 | -1.32 | N/A | $0 |
| 08/10/2018 | Q2 2018 | -$0.24 | -$2.16 | -1.92 | N/A | $0 |
| 05/14/2018 | Q1 2018 | -$0.18 | -$2.92 | -2.74 | N/A | $0 |
| 03/16/2018 | Q4 2017 | -$0.25 | -$1.99 | -1.74 | N/A | $0 |
| 11/13/2017 | Q3 2017 | -$0.17 | -$2.79 | -2.62 | N/A | $0 |
| 08/14/2017 | Q2 2017 | -$0.27 | -$2.65 | -2.38 | N/A | $0 |
| 05/12/2017 | Q1 2017 | N/A | -$2.92 | N/A | N/A | $0 |
| 03/31/2017 | Q4 2016 | N/A | -$5.85 | N/A | N/A | $0 |
| 09/29/2016 | Q3 2016 | N/A | -$3.24 | N/A | N/A | $0 |
| 06/29/2016 | Q2 2016 | N/A | -$3.82 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AzurRx BioPharma, Inc. Earnings: FAQ's
AzurRx BioPharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 16th, 2021 based offlast year's report dates.
The conference call for AzurRx BioPharma, Inc.'s latest earnings report can be listened to online.
The conference call transcript for AzurRx BioPharma, Inc.'s latest earnings report can be read online.
AzurRx BioPharma, Inc. (:AZRX) has a recorded net income of $-32,671,466.AzurRx BioPharma, Inc. has generated $-5.90290331 earnings per share over the last four quarters.
AzurRx BioPharma, Inc. (:AZRX) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.